HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (23) Citing Articles via Google Scholar Google Scholar Articles by Stöllberger, C. Articles by Finsterer, J. Search for Related Content PubMed PubMed Citation Articles by Stöllberger, C. Articles by Finsterer, J.

Elimination of the Left Atrial Appendage To Prevent Stroke or Embolism?^*

Anatomic, Physiologic, and Pathophysiologic Considerations

^* From the Medizinische Abteilung (Dr. Stöllberger) and the Neurologische Abteilung (Dr. Finsterer), Krankenanstalt Rudolfstiftung, Vienna, Austria; and the Klinik für Kardiologie (Dr. Schneider), Sana Kliniken, Lübeck, Germany.

Correspondence to: Claudia Stöllberger, MD, Steingasse 31/18, A-1030 Wien, Austria; e-mail: claudia.stoellberger{at}chello.at

The "elimination" of the left atrial appendage (LAA) seems to be an attractive alternative to oral anticoagulation in the treatment of atrial fibrillation, especially in patients with contraindications to oral anticoagulation therapy. The LAA, however, plays an important role in the maintenance and regulation of the cardiac function, in arterial hypertension, atrial fibrillation, coronary heart disease, valvular heart disease, and heart failure. Data, mainly from animal studies, indicate that elimination of the LAA may impede thirst in patients with hypovolemia, may impair hemodynamic response to volume or pressure overload, may decrease cardiac output, and may promote heart failure. It may have adverse effects in humans as well. Further studies on the hemodynamic and neurohumoral consequences of left atrial appendage elimination are required to advance our understanding of LAA physiology and pathophysiology.

Key Words: atrial fibrillation • heart failure • left atrial appendage • stroke

This article has been cited by other articles:

				K. Kamohara, K. Fukamachi, Y. Ootaki, M. Akiyama, F. Cingoz, C. Ootaki, D. G. Vince, Z. B. Popovic, M. W. Kopcak Jr, R. Dessoffy, et al. Evaluation of a novel device for left atrial appendage exclusion: The second-generation atrial exclusion device. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 340 - 346. [Abstract] [Full Text] [PDF]

				C. Stollberger, J. Finsterer, and B. Schneider Safety of Oral Anticoagulation in Elderly Atrial Fibrillation Patients to Prevent Strokes Stroke, August 1, 2006; 37(8): 1960 - 1961. [Full Text] [PDF]

				C. Stollberger, B. Schneider, and J. Finsterer Stroke prevention by means of epicardial occlusion of the left atrial appendage J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 207 - 208. [Full Text] [PDF]

				C. Stollberger, J. Finsterer, and B. Schneider Does Percutaneous Closure of the Left Atrial Appendage Prevent Stroke in Atrial Fibrillation? J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1500 - 1500. [Full Text] [PDF]

				G. Bisleri and C. Muneretto Innovative Monolateral Approach for Closed-Chest Atrial Fibrillation Surgery Ann. Thorac. Surg., November 1, 2005; 80(5): e22 - e25. [Abstract] [Full Text] [PDF]

				D. Wheatley and M. Will Mitral valve replacement with mechanical or bioprosthetic valve MMCTS, April 25, 2005; 2005(0425): 1024. [Abstract] [Full Text] [PDF]

				I. R. Hanna and P. C. Block Effects of percutaneous left atrial appendage transcatheter occlusion (PLAATO) on left atrial structure and function: Reply J. Am. Coll. Cardiol., February 15, 2005; 45(4): 635 - 635. [Full Text] [PDF]